<code id='7D60D43FD3'></code><style id='7D60D43FD3'></style>
    • <acronym id='7D60D43FD3'></acronym>
      <center id='7D60D43FD3'><center id='7D60D43FD3'><tfoot id='7D60D43FD3'></tfoot></center><abbr id='7D60D43FD3'><dir id='7D60D43FD3'><tfoot id='7D60D43FD3'></tfoot><noframes id='7D60D43FD3'>

    • <optgroup id='7D60D43FD3'><strike id='7D60D43FD3'><sup id='7D60D43FD3'></sup></strike><code id='7D60D43FD3'></code></optgroup>
        1. <b id='7D60D43FD3'><label id='7D60D43FD3'><select id='7D60D43FD3'><dt id='7D60D43FD3'><span id='7D60D43FD3'></span></dt></select></label></b><u id='7D60D43FD3'></u>
          <i id='7D60D43FD3'><strike id='7D60D43FD3'><tt id='7D60D43FD3'><pre id='7D60D43FD3'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:3692
          CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

          WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

          Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

          advertisement

          Pharmaceutical groups and patient advocates are increasingly fighting that approach.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          7 more heat
          7 more heat

          1:25Abillboarddisplaysatemperatureof118degreesFahrenheitduringarecordheatwaveinPhoenix,ArizonaonJuly

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Ending racial health disparities hinges on penalties, political will

          AdobeThenation’swidespreadracialhealthdisparitieswon’tbeerasedwithoutchangestohowhealthcaresystemsar